Market Analysis and Price Projections for the Drug NDC: 68462-0852
Introduction to the Drug
The drug with the NDC code 68462-0852 is Carvedilol, a medication used primarily for the treatment of high blood pressure and heart failure. It is a film-coated oral tablet, distributed by Glenmark Pharmaceuticals Inc., USA[1].
Market Context
US Pharmaceutical Market Overview
The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].
Generic Drugs Market
Carvedilol, being a generic drug, is part of the small molecules segment, which held the largest market share in 2022. The generic drugs market is expected to continue growing due to greater approvals of generic drugs and increasing pharmaceutical production capacity[4].
Price Projections
Overall Drug Price Inflation
According to Vizient's latest Pharmacy Market Outlook, drug price inflation is projected to grow at 3.8% in 2024, driven in part by specialty pharmacy and the increasing utilization of certain medications. This is the highest projected increase since July 2019[2].
Generic Drug Pricing
Generic drugs, such as Carvedilol, generally experience less price volatility compared to branded or specialty drugs. However, the overall trend of increasing drug prices can still impact generic medications. The rise in generic drug prices is often more stable but can be influenced by factors such as raw material costs, manufacturing capacity, and regulatory changes.
Factors Influencing Price
Regulatory and Market Dynamics
The prices of generic drugs like Carvedilol can be influenced by regulatory approvals, market competition, and supply chain dynamics. For instance, if there is a shortage of raw materials or manufacturing capacity issues, prices may rise[2].
Technological Advancements
The increasing adoption of AI-based tools in drug discovery and development could indirectly affect the pricing of existing generic drugs. While AI may accelerate the development of new medications, it could also lead to increased R&D expenditures, which might be reflected in the pricing of both new and existing drugs[4].
Industry Trends and Predictions
Role of AI in Pharma
In 2025, the pharmaceutical industry is expected to see a significant increase in the adoption of artificial intelligence (AI) in standard operations, including clinical development and data analysis. This could lead to more efficient drug development processes but may also introduce new costs that could impact pricing[3].
External Data and AI Models
The use of reliable external data to train internal data science models, including large language models (LLMs), is expected to grow. This trend could enhance the accuracy and speed of drug development but may also add to the costs associated with these advanced technologies[3].
Supply Chain and Expenditure Management
Hospital and Provider Spend
Hospitals and healthcare providers are facing increasing challenges in managing pharmacy expenditures due to drug shortages and rising costs. Effective supply chain management and strategic purchasing are becoming more critical to mitigate these issues[2].
Key Takeaways
- Market Growth: The US pharmaceutical market, including generic drugs like Carvedilol, is expected to grow significantly over the next few years.
- Price Inflation: Drug price inflation is projected to increase by 3.8% in 2024, with potential impacts on generic drugs.
- Technological Influence: The adoption of AI in drug development could influence pricing through increased R&D expenditures.
- Regulatory and Supply Chain Factors: Regulatory changes, market competition, and supply chain dynamics will continue to influence the prices of generic drugs.
FAQs
-
What is the primary use of Carvedilol?
- Carvedilol is primarily used for the treatment of high blood pressure and heart failure.
-
Who distributes Carvedilol with the NDC code 68462-0852?
- Carvedilol with the NDC code 68462-0852 is distributed by Glenmark Pharmaceuticals Inc., USA.
-
What is the projected growth rate of the US pharmaceutical market?
- The US pharmaceutical market is projected to grow at a CAGR of 5.36% from 2022 to 2030.
-
How does AI impact the pharmaceutical industry?
- AI is expected to enhance drug development processes, improve data analysis, and increase the efficiency of clinical trials, but it may also introduce new costs.
-
What factors influence the price of generic drugs like Carvedilol?
- The price of generic drugs like Carvedilol can be influenced by regulatory approvals, market competition, supply chain dynamics, and technological advancements.
Sources
- FDA.report - NDC 68462-162 Oral Tablet, Film Coated Carvedilol
- Vizient Inc. - Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
- Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
- GlobeNewswire - US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030
"Many hospitals around the country experienced a challenging 2023, including drug shortages and rising drug costs," said Carina Dolan, associate vice president, clinical oncology, pharmacoeconomics and market insights, Vizient[2].
